Skip to main content
Ikonisys S.A. logo

Ikonisys S.A. — Investor Relations & Filings

Ticker · ALIKO ISIN · FR00140048X2 LEI · 9695000B742KPNDQ4D05 PA Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2025-04-03 Regulatory Filings
Country FR France
Listing PA ALIKO

About Ikonisys S.A.

https://www.ikonisys.com

Ikonisys S.A. is a cell-based diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) technology for genetic analysis. The company develops, manufactures, and markets integrated solutions that include proprietary automated microscopy instruments, advanced software, and reagents. These systems are designed to improve efficiency, accuracy, and standardization for pathologists and laboratory technicians. Ikonisys's technology enables the precise detection and analysis of chromosomal alterations, supporting early and accurate cancer diagnosis, prognosis, and the selection and monitoring of personalized therapies. The platform's automation and digitization features streamline the entire workflow from image acquisition to quantitative interpretation for oncology and genetic testing applications.

Recent filings

Filing Released Lang Actions
Ikonisys SA: Hospitex International Launches Urine24, the First-Online Urinary Cytology Test Platform, Marking a Breakthrough in Early Bladder Cancer Diagnosis in Italy
Regulatory Filings Classification · 100% confidence The document is a press release dated April 3, 2025, announcing a significant business development: the launch of a new diagnostic service (Urine24) by the Italian subsidiary Hospitex International, owned by ALIKO SCIENTIFIC. It details market potential, technology, and future expansion plans. This type of announcement, focusing on a new product launch, market penetration, and business strategy updates, is characteristic of a general corporate announcement or press release. It is not a formal regulatory filing like a 10-K, an earnings release (ER) which focuses strictly on period results, or a specific capital/financing update (CAP). Since it is a general announcement of a major business event and does not fit the specific categories like AGM-R, 10-K, ER, or CT, the most appropriate classification is the general regulatory announcement/press release category, RNS, as it serves as a broad communication to the market about a material event.
2025-04-03 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated March 10, 2025, announcing that Hospitex (a subsidiary of ALIKO SCIENTIFIC/Ikonisys SA) has won a public tender for pathology equipment from a regional hospital in Italy. It details the contract value (€116K initial) and the technology being supplied. This type of announcement, detailing a significant business contract win, is typically classified as a general business update or news release. It does not fit the specific definitions for an Earnings Release (ER), Interim Report (IR), Annual Report (10-K), or a specific financing/share action (CAP, SHA, POS). Since it is a material, non-financial-results-focused announcement, and there isn't a specific 'Contract Win' category, the most appropriate general category is 'Regulatory Filings' (RNS), which serves as the fallback for miscellaneous regulatory or significant corporate news announcements that don't fit the other specific codes. Given the nature of the announcement (a press release about a contract), it is not a Report Publication Announcement (RPA) because it is the primary news, not an announcement *about* another report.
2025-03-10 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated March 10, 2025, announcing a significant business event: Ikonisys SA (ALIKO SCIENTIFIC) winning a public tender for a five-year supply contract with a hospital. It details the contract value, the technology involved, and provides company background information. This type of announcement, focusing on a specific business development, contract win, or material event, is typically classified as a general Regulatory Filing (RNS) if it doesn't fit a more specific category like Earnings Release (ER) or Capital Update (CAP). Since it is not a full financial report (10-K, IR), a transcript (CT), or a management discussion (MDA), and it is a formal announcement, RNS is the most appropriate general regulatory category. The document length (7350 chars) is substantial enough that it is the primary announcement itself, not just a notice of publication (RPA).
2025-03-10 English
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document is a press release dated February 27, 2025, announcing that Ikonisys has finalized a capital increase ('augmentation de capital') through a private placement. It details the amount raised (500 K€), the number of shares issued (333,333), the issue price (€1.50), and the impact on shareholding structure (dilution tables). This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report (RPA).
2025-02-27 French
Inside Information / Other news releases
Capital/Financing Update Classification · 99% confidence The document is a press release dated February 27, 2025, announcing that Ikonisys has finalized a capital increase of €500k through a private placement. This action directly relates to the company's fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition of 'Capital/Financing Update' (Code: CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it describes a specific corporate finance event.
2025-02-27 English
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release issued by ALIKO SCIENTIFIC (Ikonisys SA) announcing that its subsidiary, Hospitex, has secured a contract with the United Nations (UNOPS) for hospital IT and networking systems in Ethiopia. This is a corporate announcement regarding business operations and contract wins, which does not fit into specific financial reporting categories like 10-K, IR, or ER. As it is a general corporate announcement, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2025-02-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.